Thrombolysis and angioplasty in myocardial infarction

Harrington RA, Sane DC, Califf RM, Sigmon KN, Abbottsmith CW, Candela RJ, Lee KL, Topol EJ. Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am CoU Cardiol 1994 23(4) 891-8. 

Topol EJ, Califf RM, George BS, Kereiakes DJ, Abbottsmith CW, Candela RJ, Lee KL, Pitt B, Stack RS, O Neill WW. The thrombolysis and angioplasty in myocardial infarction (TAMI) study group. A multicenter randomized trial of intravenons recombinant tissue plasminogen activator and inunediate angioplasty in acute myocardial infarction. N Eng J Med 1987 317 581-588. 

Kleiman NS, Ohman EM, Califf RM, George BS, Kereiakes D, Aguirre FV, Weisman H, Schaible T, Topol EJ. Profound inhibition of platelet aggregation with monoclonal antibody 7E3 Eab after thrombolytic therapy. Results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMl) 8 Pilot Study. J Am CoU Cardiol. 1993 22 381-389. 

---